IbogaineVault / Portal / Outcomes

Ibogaine microdosing in a patient with bipolar depression: case report

Carlucci, Roberta, Senhorinho, Beatriz Di Magno Camurugi, Teixeira, Isabela Neri · 2025 · Archives of Health

Outcomes Case report moderate

AI-extracted · unverified · confirm at source

Microdosing (3mg/72h, 12 weeks) in treatment-resistant bipolar II: 60% HAM-D improvement, no hypomania, stable cardiovascular. Single case, Brazilian regulatory context.

Dosing: 3mg every 72 hours (sub-psychoactive) (oral)

Sample size: 1

View primary source ↗View entry in vault ↗